Michael Mina

Dr. Mina is a medical advisor at Nolla Health. He is a physician-scientist and epidemiologist who earned his BA in Engineering and Global Health at Dartmouth and his MD and PhD at Emory through the NIH Medical Scientist Training Program, with doctoral work spanning the CDC, a respiratory pathogens unit in Johannesburg, and St. Jude Children's Research Hospital.

During postdoctoral fellowships at Princeton (under Bryan Grenfell) and Harvard Medical School (with Stephen Elledge), he led the research that established "immune amnesia"-- the discovery that measles infection erases much of a person's pre-existing immunological memory, a finding published in Science that reframed measles vaccination as arguably the single most consequential intervention in childhood infectious disease mortality. He completed his clinical pathology residency at Brigham & Women's and joined the faculty of Harvard Medical School and the T.H. Chan School of Public Health.

During COVID-19 he became the most visible national advocate for rapid at-home antigen testing, arguing that cheap, frequent tests were a better tool for slowing spread than the more sensitive PCR tests the public health establishment was anchored to — a position that made him a regular presence on op-ed pages and advisory calls with both the Trump and Biden White Houses. He has authored more than 80 peer-reviewed papers and is a recipient of the NIH Director's Early Independence Award.